Xconomy’s Digital Events →
Martin Tolar is CEO of Lexington, MA-based Alzheon
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Sponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
From Our Editors · Podcast
The AI, Big Data, and R&D Boom
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.